Authenticity and drug resistance in a panel of acute lymphoblastic leukaemia cell lines

被引:28
作者
Beesley, A. H.
Palmer, M-L
Ford, J.
Weller, R. E.
Cummings, A. J.
Freitas, J. R.
Firth, M. J.
Perera, K. U.
de Klerk, N. H.
Kees, U. R. [1 ]
机构
[1] Univ Western Australia, Div Children Keukaemia & Canc Res, Perth, WA 6009, Australia
[2] Univ Western Australia, Ctr Child Hlth Res, Perth, WA 6009, Australia
[3] Univ Western Australia, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia
[4] Curtin Univ Technol, Sch Pharm, Perth, WA 6001, Australia
[5] Univ Western Australia, Ctr Child hlth Res, Nedlands, WA 6009, Australia
[6] Univ Western Australia, Div Biostat & Genet Epidemiol, Telethon Inst Child Hlth Res, Nedlands, WA 6009, Australia
基金
英国医学研究理事会;
关键词
acute lymphoblastic leukaemia; drug resistance; cell line; methotrexate; glucocorticoid; fingerprint;
D O I
10.1038/sj.bjc.6603447
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cell lines are important models for drug resistance in acute lymphoblastic leukaemia (ALL), but are often criticised as being unrepresentative of primary disease. There are also doubts regarding the authenticity of many lines. We have characterised a panel of ALL cell lines for growth and drug resistance and compared data with that published for primary patient specimens. In contrast to the convention that cell lines are highly proliferative, those established in our laboratory grow at rates similar to estimates of leukaemic cells in vivo (doubling time 53-442 h). Authenticity was confirmed by genetic fingerprinting, which also demonstrated the potential stability of long-term cultures. In vitro glucocorticoid resistance correlated well with that measured ex vivo, but all lines were significantly more sensitive to vincristine than primary specimens. Sensitivity to methotrexate was inversely correlated to that of glucocorticoids and L-asparaginase, indicating possible reciprocity in resistance mechanisms. A cell line identified as highly methotrexate resistant (IC50 > 8000-fold higher than other lines) was derived from a patient receiving escalating doses of the drug, indicating in vivo selection of resistance as a cause of relapse. Many of these lines are suitable as models to study naturally occurring resistance phenotypes in paediatric ALL.
引用
收藏
页码:1537 / 1544
页数:8
相关论文
共 48 条
  • [1] THE CYTOTOXICITY OF THIOGUANINE VS MERCAPTOPURINE IN ACUTE LYMPHOBLASTIC-LEUKEMIA[J]. ADAMSON, PC;POPLACK, DG;BALIS, FM. LEUKEMIA RESEARCH, 1994(11)
  • [2] ALLEY MC, 1988, CANCER RES, V48, P589
  • [3] Pharmacokinetics and pharmacodynamics of oral methotrexate and mercaptopurine in children with lower risk acute lymphoblastic leukemia: A joint Children's Cancer Group and Pediatric Oncology Branch Study[J]. Balis, FM;Holcenberg, JS;Poplack, DG;Ge, J;Sather, HN;Murphy, RF;Ames, MM;Waskerwitz, MJ;Tubergen, DG;Zimm, S;Gilchrist, GS;Bleyer, WA. BLOOD, 1998(10)
  • [4] High level resistance to glucocorticoids, associated with a dysfunctional glucocorticoid receptor, in childhood acute lymphoblastic leukemia cells selected for methotrexate resistance[J]. Catts, VS;Farnsworth, ML;Haber, M;Norris, MD;Lutze-Mann, LH;Lock, RB. LEUKEMIA, 2001(06)
  • [5] Cell division rates of primary human precursor B cells in culture reflect in vivo rates[J]. Cooperman, J;Neely, R;Teachey, DT;Grupp, S;Choi, JK. STEM CELLS, 2004(06)
  • [6] False leukemia-lymphoma cell lines: an update on over 500 cell lines[J]. Drexler, HG;Dirks, WG;Matsuo, Y;MacLeod, RAF. LEUKEMIA, 2003(02)
  • [7] Mix-ups and mycoplasma: the enemies within[J]. Drexler, HG;Uphoff, CC;Dirks, WG;MacLeod, RAF. LEUKEMIA RESEARCH, 2002(04)
  • [8] Guidelines for the characterization and publication of human malignant hematopoietic cell lines[J]. Drexler, HG;Matsuo, Y. LEUKEMIA, 1999(06)
  • [9] Effects of interleukin 3, interleukin 7, and B-cell growth factor on proliferation and drug resistance in vitro in childhood acute lymphoblastic leukemia[J]. Duyn, AEJ;Kaspers, GJL;Pieters, R;Van Zantwijk, CH;Broekema, GJ;Hählen, K;Veerman, AJP. ANNALS OF HEMATOLOGY, 1999(04)
  • [10] Fine BM, 2005, CANCER RES, V65, P291